Omada Health has announced five new senior hires, most notably a new chief medical officer, Dr. Paul Chew, who previously served as senior VP and global chief medical officer at Sanofi. The company also announced the hire of Tom Schoenherr as chief commercial officer, a position he previously held at Counsyl.
The Centers for Medicare and Medicaid Services has deemed certain therapeutic continuous blood glucose meters (CGMs) as durable medical equipment and thus are eligible for coverage. Eligible devices must fit several definitions: they must be a class III, FDA-approved device, and they must be CGMs that measure blood glucose levels periodically by using sensors, a receiver and transmitter and eliminate the need for blood glucose strips, informing patients and their doctors in treatment decisions. One such device does make the cut: the Dexcom G5 Mobile, and it’s currently the only one that falls within the CMS’s new benefit category classification.
#cgm
Minnesota-based Pops! Diabetes Care , which is working on a digital device and diabetes management platform, has raised a little over $1.2 million to bring its product to market. MedCity News confirmed the funding with Pops! CEO and cofounder Lonny Stormo, who previously served in executive roles at Medtronic. The Pops! system consists of an integrated blood glucose meter affixed to the back of a user’s smartphone and a Bluetooth-connected companion app.
#bgm
#mobile app
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin. The clearance is for prescription use, but includes two versions of the app: Go Dose, for patients, and Go Dose Pro, for healthcare providers. "The Go Dose System, comprised of the Go Dose and Go Dose Pro applications, is for use in home and clinical settings to aid in the review, analysis, and evaluation of historical blood glucose test values to support type 2 diabetes mellitus management," the company writes in the submission document.
#mobile app
Smart connected insulin pen cap maker Common Sensing has partnered with Welkin Health, a digital health company that assists healthcare organizations in developing coaching programs. Using the insulin dosing and blood glucose data wirelessly transmitted from Common Sensing’s Gocap, the Welkin Health coaches will monitor the daily behavior of patients and work with them to manage their diabetes.
#product & service
#insulin pen
#coaching
The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform. Through this 510(k) class II clearance, WellDoc will now offer BlueStar and BlueStar Rx, allowing the company to offer the product through more channels. Both versions analyze diabetes data entered by the patient, comparing past data trends to form personalized guidance and creating a summary of curated data analytics to the healthcare team for clinical decision support, but the non-prescription version will not feature the insulin calculator that the full version does.
#mobile app
Pharmaceutical company Boehringer Ingelheim is partnering with Inovalon, a data analytics company that provides cloud-based platforms to the healthcare industry to facilitate the shift from volume to value-based care, on behalf of Boehringer Ingelheim’s diabetes alliance with Eli Lilly. Leveraging Inovalon’s platform, the partnership will work to support outcomes-based contracting, taking clinical outcomes into real-world practice to improve patient care.
#product & service
Milpitas, California-based Bigfoot Biomedical, a diabetes management company working on their first product, announced an investment from the Juvenile Diabetes Research Foundation (JDRF)’s newly launched venture fund, T1D, focused on early stage companies working on type 1 diabetes. The terms of the investment were not disclosed, but Bigfoot previously raised $35.5 million . The funding will be used to further develop Bigfoot’s automated insulin delivery service called smartloop. he cloud-connected diabetes management system is designed to interface with wearable insulin delivery and glucose monitoring tools, accessed through a companion app, and all delivered through a monthly bundled subscription service.
Analyte Health, Inc., an integrated health care partner that connects patients and telehealth providers with laboratory testing services inckuding diabetes tests, and Teladoc, Inc.announced a partnership that delivers lab diagnostics services through the Teladoc telehealth platform.
#product & service
#telehealth
#virtual care
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P. Morgan Healthcare Conference on Wednesday, January 11, 2017, at 11:30 a.m. EST.